This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY Disorders of sex development (DSD). Clin Endo-crinol (Oxf). 2009; 70(2): 173-187.MendoncaBBDomeniceSArnholdIJCostaEM46,XY Disorders of sex development (DSD)200970217318710.1111/j.1365-2265.2007.02993.x-i1Search in Google Scholar
Hochberg Z, Chayen R, Reiss N, Falik Z, Makler A, Munichor M, et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab. 1996; 81(8): 2821-2827.HochbergZChayenRReissNFalikZMaklerAMunichorMClinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency19968182821282710.1210/jcem.81.8.8768837Search in Google Scholar
Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, et al. Phenotypical, biological, and molecular heterogeneity of 5 α-reductase deficiency: An extensive international experience of 55 patients. J Clin Endocrinol Metab. 2011; 96(2): 296-307.MaimounLPhilibertPCammasBAudranFBouchardPFenichelPPhenotypical, biological, and molecular heterogeneity of 5 α-reductase deficiency: An extensive international experience of 55 patients201196229630710.1210/jc.2010-1024Search in Google Scholar
Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5 α-reductase 2 gene in male pseudo-hermaphroditism. Nature. 1991; 354(6349): 159-161.AnderssonSBermanDMJenkinsEPRussellDWDeletion of steroid 5 α-reductase 2 gene in male pseudo-hermaphroditism1991354634915916110.1038/354159a0Search in Google Scholar
Vilchis F, Ramos L, Mendez JP, Benavides S, Canto P, Chavez B. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: The P212R substitution of the steroid 5 α-reductase 2 may constitute an ancestral founder mutation in Mexican patients. J Androl. 2010; 31(4): 358-364.VilchisFRamosLMendezJPBenavidesSCantoPChavezBMolecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: The P212R substitution of the steroid 5 α-reductase 2 may constitute an ancestral founder mutation in Mexican patients201031435836410.2164/jandrol.109.009407Search in Google Scholar
Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5 α-reductase-2 deficiency. Mol Cell Endocrinol. 2002; 198(1-2): 51-59.Imperato-McGinleyJZhuYSAndrogens and male physiology the syndrome of 5 α-reductase-2 deficiency20021981-2515910.1016/S0303-7207(02)00368-4Search in Google Scholar
Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, Homma K, et al. Micropenis and the 5 α-reductase-2 (SR-D5A2) gene: Mutation and V89L polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab. 2003; 88(7): 3431-3436.SasakiGOgataTIshiiTKosakiKSatoSHommaKMicropenis and the 5 α-reductase-2 (SR-D5A2) gene: Mutation and V89L polymorphism analysis in 81 Japanese patients20038873431343610.1210/jc.2002-02141512843198Search in Google Scholar
Thigpen AE, Davis DL, Gautier T, Imperato-McGinley J, Russell DW. Brief report: The molecular basis of steroid 5 α-reductase deficiency in a large Dominican kindred. N Engl J Med. 1992; 327(17): 1216-1219.ThigpenAEDavisDLGautierTImperato-McGinleyJRussellDWBrief report: The molecular basis of steroid 5 α-reductase deficiency in a large Dominican kindred1992327171216121910.1056/NEJM1992102232717061406794Search in Google Scholar
Alswailem MM, Alzahrani OS, Alghofaili L, Qasem E, Almohanaa M, Alsagheir A, et al. Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population. Endocrine. 2019; 63(2): 361-368.AlswailemMMAlzahraniOSAlghofailiLQasemEAlmohanaaMAlsagheirAMolecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population201963236136810.1007/s12020-018-1767-130269266Search in Google Scholar
M Selveindran N, Syed Zakaria SZ, Jalaludin MY, Rasat R. Quality of life in children with disorders of sex development. Horm Res Paediatr. 2017; 88(5): 324-330.M SelveindranNSyed ZakariaSZJalaludinMYRasatRQuality of life in children with disorders of sex development201788532433010.1159/00047878028965114Search in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.RichardsSAzizNBaleSBickDDasSGastier-FosterJStandards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology201517540542410.1038/gim.2015.30454475325741868Search in Google Scholar
Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, et al. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf). 2005; 63(4): 375-380.NicolettiABaldazziLBalsamoABarpLPirazzoliPGennariMSRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects200563437538010.1111/j.1365-2265.2005.02348.x16181229Search in Google Scholar
Avendano A, Paradisi I, Cammarata-Scalisi F, Callea M. 5-α-Reductase type 2 deficiency: Is there a genotype-phenotype correlation? A review. Hormones (Athens). 2018; 17(2): 197-204.AvendanoAParadisiICammarata-ScalisiFCalleaM5-α-Reductase type 2 deficiency: Is there a genotype-phenotype correlation? A review201817219720410.1007/s42000-018-0013-9Search in Google Scholar
Andonova S, Robeva R, Vazharova R, Ledig S, Grozdanova L, Stefanova E, et al. New territory for an old disease: 5-α-reductase type 2 deficiency in Bulgaria. Sex Dev. 2017; 11(1): 21-28.AndonovaSRobevaRVazharovaRLedigSGrozdanovaLStefanovaENew territory for an old disease: 5-α-reductase type 2 deficiency in Bulgaria2017111212810.1159/000454974Search in Google Scholar
Perry RJ, Novikova E, Wallace AM, Donaldson MD. Pitfalls in the diagnosis of 5 α-reductase type 2 deficiency during early infancy. Horm Res Paediatr. 2011; 75(5): 380-382.PerryRJNovikovaEWallaceAMDonaldsonMDPitfalls in the diagnosis of 5 α-reductase type 2 deficiency during early infancy201175538038210.1159/000324646Search in Google Scholar
Chan AO, But BW, Lee CY, Lam YY, Ng KL, Tung JY, et al. Diagnosis of 5 α-reductase 2 deficiency: Is measurement of dihydrotestosterone essential? Clin Chem. 2013; 59(5): 798-806.ChanAOButBWLeeCYLamYYNgKLTungJYDiagnosis of 5 α-reductase 2 deficiency: Is measurement of dihydrotestosterone essential?201359579880610.1373/clinchem.2012.196501Search in Google Scholar
Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, et al. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5 α-reductase deficiency type 2. J Mol Med (Berl). 2005; 83(7): 569-576.HackelCOliveiraLEFerrazLFToniniMMSilvaDNTorallesMBNew mutations, hotspots, and founder effects in Brazilian patients with steroid 5 α-reductase deficiency type 2200583756957610.1007/s00109-005-0651-7Search in Google Scholar
Karczewski K, Francioli L. The genome Aggregation Database (gnomAD). MacArthur Lab. 2017. https://macarthurlab.org/2017/02/27/the-genome-aggregation-database-gnomadKarczewskiKFrancioliLThe genome Aggregation Database (gnomAD)2017https://macarthurlab.org/2017/02/27/the-genome-aggregation-database-gnomadSearch in Google Scholar
Silveri RI, Russell DW. 5 α-Reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol. 1999; 162(3): 1142-1145.SilveriRIRussellDW5 α-Reductase type 2 mutations are present in some boys with isolated hypospadias199916231142114510.1016/S0022-5347(01)68102-3Search in Google Scholar
Rahimi M, Ghanbari M, Fazeli Z, Rouzrokh M, Om-rani S, Mirfakhraie R, et al. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population. J Endocrinol Invest. 2017; 40(4): 391-396.RahimiMGhanbariMFazeliZRouzrokhMOm-raniSMirfakhraieRAssociation of SRD5A2 gene mutations with risk of hypospadias in the Iranian population201740439139610.1007/s40618-016-0573-y27848231Search in Google Scholar
Samtani R, Bajpai M, Ghosh P, Saraswathy K. SR-D5A2 gene mutations – A population-based review. Pediatr Endocrinol Rev. 2010; 8(1): 34-40.SamtaniRBajpaiMGhoshPSaraswathyKSR-D5A2 gene mutations – A population-based review2010813440Search in Google Scholar
Fang C, Guo ZQ, Chen XY, Liu TZ, Zeng XT, Wang XH. Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications. Medicine (Baltimore). 2017; 96(19): e6791.FangCGuoZQChenXYLiuTZZengXTWangXHRelationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications20179619e679110.1097/MD.0000000000006791542858828489754Search in Google Scholar
Pearce CL, van den Berg DJ, Makridakis N, Reichardt JK, Ross RK, Pike MC, et al. No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: Lessons learned. Hum Mol Genet. 2008; 17(16): 2456-2461.PearceCLvan den BergDJMakridakisNReichardtJKRossRKPikeMCNo association between the SRD5A2 gene A49T missense variant and prostate cancer risk: Lessons learned200817162456246110.1093/hmg/ddn145272288518469342Search in Google Scholar
Costa EM, Domenice S, Sircili MH, Inacio M, Mendonca BB. DSD due to 5 α-reductase 2 deficiency – From diagnosis to long term outcome. Semin Reprod Med. 2012; 30(5): 427-431.CostaEMDomeniceSSirciliMHInacioMMendoncaBBDSD due to 5 α-reductase 2 deficiency – From diagnosis to long term outcome201230542743110.1055/s-0032-132472723044880Search in Google Scholar
Byers HM, Mohnach LH, Fechner PY, Chen M, Thomas IH, Ramsdell LA, et al. Unexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-α reductase type 2 deficiency. Am J Med Genet C Semin Med Genet. 2017; 175(2): 260-267.ByersHMMohnachLHFechnerPYChenMThomasIHRamsdellLAUnexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-α reductase type 2 deficiency2017175226026710.1002/ajmg.c.31560548913028544750Search in Google Scholar
Houk CP, Lee PA. Consensus statement on terminology and management: Disorders of sex development. Sex Dev. 2008; 2(4-5): 172-180.HoukCPLeePAConsensus statement on terminology and management: Disorders of sex development200824-517218010.1159/00015203218987491Search in Google Scholar
Wisniewski AB, Mazur T. 46,XY DSD with female or ambiguous external genitalia at birth due to androgen insensitivity syndrome, 5 α-reductase-2 deficiency, or 17 β-hydroxysteroid dehydrogenase deficiency: A review of quality of life outcomes. Int J Pediatr Endocrinol. 2009; 2009: 567430.WisniewskiABMazurT46,XY DSD with female or ambiguous external genitalia at birth due to androgen insensitivity syndrome, 5 α-reductase-2 deficiency, or 17 β-hydroxysteroid dehydrogenase deficiency: A review of quality of life outcomes2009200956743010.1186/1687-9856-2009-567430Search in Google Scholar
Fenichel P, Paris F, Philibert P, Hieronimus S, Gaspari L, Kurzenne JY, et al. Molecular diagnosis of 5 α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperan-drogenism. J Clin Endocrinol Metab. 2013; 98(6): E1055-E1059.FenichelPParisFPhilibertPHieronimusSGaspariLKurzenneJYMolecular diagnosis of 5 α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperan-drogenism2013986E1055E105910.1210/jc.2012-389323633205Search in Google Scholar